Nidan Laboratories and Healthcare Limited
Nidan Laboratories and Healthcare Limited scores highest on Price (68) and lowest on Nitro (17). Its PosiPenta is 42.40 out of 100, around the middle of similar companies.
On the Penta Grid this week, Nidan Laboratories and Healthcare Limited is Grid #1,664 of 2,356 in India.
Compared with similar companies in India.
The five pillars
Details
PPrice
| P/E ratio | 30.56 |
| P/B ratio | 0.27 |
EEarnings
| Trailing EPS | — |
| Forward EPS | — |
NNitro
| Price | 13.00 |
| 52-week high | 24.90 |
| 52-week low | 11.50 |
| Fall from 52-week high | 47.8% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.16 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹18 Cr |
| Promoter holding | 57.04% |
| Dividend yield | — |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Nidan Laboratories and Healthcare Limited's PosiPenta score?
Nidan Laboratories and Healthcare Limited's PosiPenta is 42.40 out of 100 for the week of 17 Oct 2026, based on 4 of 5 pillars.
Where does Nidan Laboratories and Healthcare Limited stand on the Penta Grid?
On the Penta Grid this week, Nidan Laboratories and Healthcare Limited is Grid #1,664 of 2,356 in India.
Which PosiPenta pillar is strongest for Nidan Laboratories and Healthcare Limited?
Price (valuation), with a score of 68 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Nidan Laboratories and Healthcare Limited?
Nitro (momentum), with a score of 17 out of 100: much weaker than most similar companies.
Has Nidan Laboratories and Healthcare Limited's PosiPenta changed since last week?
Yes, it fell 2.48 points, from 44.88 to 42.40.
PositoAI is for research and education only and is not investment advice.